Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo (Q37718461)
Jump to navigation
Jump to search
scientific article published on February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo |
scientific article published on February 2014 |
Statements
1 reference
Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo (English)
1 reference
Anna Goc
1 reference
Belal Al-Husein
1 reference
Katerina Katsanevas
1 reference
Alison Steinbach
1 reference
Uvette Lou
1 reference
Harika Sabbineni
1 reference
David L DeRemer
1 reference
Payaningal R Somanath
1 reference
1 reference
1 reference
1 reference